Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.
作者： Cornelia Braicu , Roxana Chiorean , Alexandru Irimie , Sergiu Chira , Ciprian Tomuleasa
DOI: 10.1017/ERM.2016.17
关键词: Neovascularization 、 Breast cancer 、 Semaphorin 、 Angiogenesis 、 Metastasis 、 Immunology 、 Biomarker (cell) 、 Triple Negative Breast Neoplasms 、 Disease 、 Biology 、 Cancer research
摘要: … Sema 6D has been connected with breast cancer patients, … However, lncRNAs do not appear to be directly related to … One of the first lcRNAs connected to cancer was the H19 gene, …
elsevier.com
sci-hub.se 
researchgate.net 参考文章(152)
Philip M. Spanheimer, Allison W. Lorenzen, James P. De Andrade, Mikhail V. Kulak, Jennifer C. Carr, George W. Woodfield, Sonia L. Sugg, Ronald J. Weigel, Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer. Annals of Surgical Oncology. ,vol. 22, pp. 4287- 4294 ,(2015) , 10.1245/S10434-015-4597-X
Lamis Yehia, Fouad Boulos, Mark Jabbour, Ziyad Mahfoud, Najla Fakhruddin, Marwan El-Sabban, Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy PLOS ONE. ,vol. 10, pp. e0129356- ,(2015) , 10.1371/JOURNAL.PONE.0129356
Nairi Abedi, Samira Mohammadi-Yeganeh, Ameneh Koochaki, Fariba Karami, Mahdi Paryan, miR-141 as potential suppressor of β-catenin in breast cancer. Tumor Biology. ,vol. 36, pp. 9895- 9901 ,(2015) , 10.1007/S13277-015-3738-Y
Carly Bess Williams, Adam C. Soloff, Stephen P. Ethier, Elizabeth S. Yeh, Perspectives on Epidermal Growth Factor Receptor Regulation in Triple-Negative Breast Cancer: Ligand-Mediated Mechanisms of Receptor Regulation and Potential for Clinical Targeting. Advances in Cancer Research. ,vol. 127, pp. 253- 281 ,(2015) , 10.1016/BS.ACR.2015.04.008
Abeer Bahnassy, Marwa Mohanad, Manal F. Ismail, Sabry Shaarawy, Ahmed El-Bastawisy, Abdel-Rahman N. Zekri, Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt. Experimental and Molecular Pathology. ,vol. 99, pp. 303- 311 ,(2015) , 10.1016/J.YEXMP.2015.07.014
Zoë Davison, Gail E. de Blacquière, Bruce R. Westley, Felicity E.B. May, Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy Neoplasia. ,vol. 13, pp. 504- 515 ,(2011) , 10.1593/NEO.101590
Eddy Pasquier, Joseph Ciccolini, Manon Carre, Sarah Giacometti, Raphaelle Fanciullino, Charlotte Pouchy, Marie-Pierre Montero, Cindy Serdjebi, Maria Kavallaris, Nicolas André, Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment Oncotarget. ,vol. 2, pp. 797- 809 ,(2011) , 10.18632/ONCOTARGET.343
R. Joseph Bender, Feilim Mac Gabhann, Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0061788
Anastassia Serguienko, Iwona Grad, Anna B. Wennerstrøm, Leonardo A. Meza-Zepeda, Bernd Thiede, Eva W. Stratford, Ola Myklebost, Else Munthe, Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA Oncotarget. ,vol. 6, pp. 2451- 2465 ,(2015) , 10.18632/ONCOTARGET.3235
Michael J. Duffy, John Crown, Maeve Mullooly, ADAM10 and ADAM17: New Players in Trastuzumab Resistance Oncotarget. ,vol. 5, pp. 10963- 10964 ,(2014) , 10.18632/ONCOTARGET.2794